Teva Pharmaceutical Industries, Eli Lilly, Pfizer, Johnson & Johnson, Purdue Pharma, Endo Pharmaceuticals, Forest Laboratories, GlaxoSmithKline, F. Hoffmann-La Roche, Baxter International and Valeant Pharmaceuticals International are some of the major players in the global postoperative pain management market.
Postoperative pain management decreases the likelihood of pulmonary, cardiac and neuropathic pain complications and aids in minimizing the cost of hospital stay. An increasing number of surgeries and greater demand for pain management treatment drives this market’s growth.
More articles on anesthesia:
FDA declares kratom unsafe ‘opioid,’ supporters of kratom disagree: 6 insights
FDA releases revised opioid blueprint to educate prescribers, mitigate opioid crisis: 4 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
